RIVA-PCI Registry - Prospective Registry of Rivaroxaban in Patients With Atrial Fibrillation
Phase of Trial: Phase IV
Latest Information Update: 06 Mar 2018
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Atrial fibrillation; Coronary thrombosis; Thrombosis
- Focus Therapeutic Use
- 06 Mar 2018 Last checked against ClinicalTrials.gov record.
- 27 Feb 2018 Status changed from not yet recruiting to recruiting.
- 25 Oct 2017 New trial record